CI
CVS icon

Cambiar Investors’s CVS Health CVS Stock Holding History

Cambiar Investors’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-538,468
Closed -$43.8M – 172
2017
Q3 		$43.8M Sell
538,468
-294,503
-35% -$23.3M 0.69% 37
2017
Q2 		$67M Buy
832,971
+982
+0.1% +$77.5K 1.05% 24
2017
Q1 		$65.3M Sell
831,989
-14,761
-2% -$1.18M 1.09% 23
2016
Q4 		$66.8M Buy
846,750
+22,802
+3% +$1.85M 1.15% 21
2016
Q3 		$73.3M Sell
823,948
-71,736
-8% -$6.77M 1.07% 35
2016
Q2 		$85.8M Sell
895,684
-22,967
-3% -$2.29M 1.22% 27
2016
Q1 		$95.3M Sell
918,651
-148,741
-14% -$14.5M 1.37% 21
2015
Q4 		$104M Buy
1,067,392
+358,541
+51% +$35.1M 1.5% 19
2015
Q3 		$68.4M Sell
708,851
-19,675
-3% -$2.07M 1.01% 41
2015
Q2 		$76.4M Sell
728,526
-129,298
-15% -$13.2M 1.07% 35
2015
Q1 		$88.5M Buy
857,824
+60,253
+8% +$6.1M 1.29% 25
2014
Q4 		$76.8M Sell
797,571
-242,075
-23% -$21.3M 1.17% 29
2014
Q3 		$82.7M Sell
1,039,646
-307,547
-23% -$24.2M 1.18% 35
2014
Q2 		$102M Sell
1,347,193
-42,762
-3% -$3.23M 1.42% 25
2014
Q1 		$104M Sell
1,389,955
-76,152
-5% -$5.38M 1.54% 18
2013
Q4 		$105M Sell
1,466,107
-182,619
-11% -$11.7M 1.55% 22
2013
Q3 		$93.6M Buy
1,648,726
+153,736
+10% +$9.16M 1.53% 27
2013
Q2 		$85.5M Buy
+1,494,990
New +$86.6M 1.38% 34

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Cambiar Investors's CVS Position: Q4 2017 in Review

Cambiar Investors sold out of CVS Health (CVS) in Q4 2017, closing a stake of 538,468 shares — an estimated $43.8M sold.

Cambiar Investors first reported a position in CVS in Q2 2013 and held it in 18 quarters. The position peaked at $105M in Q4 2013. 1,598 funds tracked by Wall St. Rank hold CVS as of Q4 2017.

  • Cambiar Investors reported no remaining CVS Health position as of Q4 2017 after selling out during the quarter.
  • Cambiar Investors sold 538,468 CVS Health shares in Q4 2017, an estimated $43.8M.
  • Cambiar Investors first reported a position in CVS Health in Q2 2013 and held it in 18 quarters.
  • Cambiar Investors's CVS Health position peaked at $105M in Q4 2013.
  • 1,598 funds tracked by Wall St. Rank held CVS Health as of Q4 2017.

Based on Cambiar Investors's 13F filing for Q4 2017, filed 30 Jan 2018.